VCYT
#1579
Veracyte, Inc. - Common Stock
44.9 2 USD
+0.03%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+3.43%
Changement Mensuel
-3.11%
Evolution sur 6 mois
+28.16%
Changement Annuel
+21.73%
Clôture Précédente
43.4 3
Open
44.7 7
Low
44.6 0
High
45.0 0
Volume
1 008
Financials
- Market Capitalization 3.61 B
- Employee 755
- Founded 2006
- CEO N/A
- Website www.veracyte.com
- Headquarter Delaware, United States
- FIGI BBG001J2M542
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
41.95
ratio cours/chiffre d'affaires
8.46
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1563 |  TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 82.80 USD | +11.82% | +17.20% | +40.32% | +25.34% | 3.63 B USD | ||
| 1567 |  DNLI Denali Therapeutics Inc. - Common Stock | 22.87 USD | -1.72% | -6.92% | +0.09% | +41.43% | 3.66 B USD | ||
| 1627 |  ABCL AbCellera Biologics Inc. - Common Shares | 11.36 USD | +0.71% | -7.19% | +99.30% | +179.80% | 3.48 B USD | ||
| 1639 |  GPCR Structure Therapeutics Inc - American Depositary Shares | 47.77 USD | +1.36% | -3.20% | -0.48% | +78.65% | 3.41 B USD |